Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaela Fontanella

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|July 14, 2016
Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem CellsAlessandra Pelagalli, Anna Nardelli, Raffaela Fontanella, et al.
Cancer Letters|November 1, 2015
A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasionRaffaela Fontanella, Alessandra Pelagalli, Anna Nardelli, et al.
Molecular Therapy. Nucleic Acids|September 21, 2016
Targeting Insulin Receptor with a Novel Internalizing AptamerMargherita Iaboni, Raffaela Fontanella, Anna Rienzo, et al.
Theranostics|September 16, 2017
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ AptamerSimona Camorani, Billy Samuel Hill, Raffaela Fontanella, et al.
Molecular Therapy. Nucleic Acids|April 26, 2016
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAILMargherita Iaboni, Valentina Russo, Raffaela Fontanella, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|July 14, 2016
Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem CellsAlessandra Pelagalli, Anna Nardelli, Raffaela Fontanella, et al.
Cancer Letters|November 1, 2015
A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasionRaffaela Fontanella, Alessandra Pelagalli, Anna Nardelli, et al.
Molecular Therapy. Nucleic Acids|September 21, 2016
Targeting Insulin Receptor with a Novel Internalizing AptamerMargherita Iaboni, Raffaela Fontanella, Anna Rienzo, et al.
Theranostics|September 16, 2017
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ AptamerSimona Camorani, Billy Samuel Hill, Raffaela Fontanella, et al.
Molecular Therapy. Nucleic Acids|April 26, 2016
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAILMargherita Iaboni, Valentina Russo, Raffaela Fontanella, et al.
Pageof 1